5’-O-Acetyl-2’,3’-dideoxy-2’,3’-didehydro-uridine

• UNSPSC Description:

  5’-O-Acetyl-2’,3’-dideoxy-2’,3’-didehydro-uridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].

• Target Antigen:

  Nucleoside Antimetabolite/Analog

• Type:

  Oligonucleotides

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/5-o-acetyl-2-3-dideoxy-2-3-didehydro-uridine.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(C=C1)NC(N1[C@@H]2O[C@H](COC(C)=O)C=C2)=O

• Molecular Weight:

  252.22

• References & Citations:

  [1]Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  42867-74-3